Merseburger AS - Search Results

1

De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival.

Mittelbronn M, Capper D, Bunz B, Dietz K, Goeppert B, Ajaaj R, Tabatabai G, Stubenvoll F, Schlaszus H, Merseburger AS, Becker R, Freudenstein D, Wick W, Weller M, Meyermann R, Simon P. Mittelbronn M, et al. Among authors: merseburger as. Neuropathol Appl Neurobiol. 2007 Jun;33(3):299-307. doi: 10.1111/j.1365-2990.2006.00820.x. Neuropathol Appl Neurobiol. 2007. PMID: 17493011

2

Differential regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) splice variants based on alternative initiation of transcription.

Simon P, Schneck M, Hochstetter T, Koutsouki E, Mittelbronn M, Merseburger A, Weigert C, Niess A, Lang F. Simon P, et al. Cell Physiol Biochem. 2007;20(6):715-28. doi: 10.1159/000110432. Cell Physiol Biochem. 2007. PMID: 17982254 Free article.

3

Activation of PI3K is associated with reduced survival in renal cell carcinoma.

Merseburger AS, Hennenlotter J, Kuehs U, Simon P, Kruck S, Koch E, Stenzl A, Kuczyk MA. Merseburger AS, et al. Urol Int. 2008;80(4):372-7. doi: 10.1159/000132694. Epub 2008 Jun 27. Urol Int. 2008. PMID: 18587247

4

Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.

Merseburger AS, Hennenlotter J, Simon P, Kruck S, Koch E, Horstmann M, Kuehs U, Küfer R, Stenzl A, Kuczyk MA. Merseburger AS, et al. Anticancer Res. 2005 May-Jun;25(3B):1901-7. Anticancer Res. 2005. PMID: 16158924 Free article.

5

PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.

Hennenlotter J, Ohneseit PA, Simon P, Merseburger AS, Serth J, Kuehs U, Kramer M, Hartmann JT, Stenzl A, Kuczyk MA. Hennenlotter J, et al. Among authors: merseburger as. Oncol Rep. 2008 May;19(5):1141-7. Oncol Rep. 2008. PMID: 18425369

6

Cathepsin D expression in renal cell cancer-clinical implications.

Merseburger AS, Hennenlotter J, Simon P, Ohneseit PA, Kuehs U, Kruck S, Koch E, Vogel U, Stenzl A, Kuczyk MA. Merseburger AS, et al. Eur Urol. 2005 Sep;48(3):519-26. doi: 10.1016/j.eururo.2005.03.019. Epub 2005 Apr 7. Eur Urol. 2005. PMID: 16115525

7

Tissue microarrays: applications in urological cancer research.

Merseburger AS, Anastasiadis AG, Hennenlotter J, Schilling D, Simon P, Machtens SA, Serth J, Stenzl A, Kuczyk MA. Merseburger AS, et al. World J Urol. 2006 Nov;24(5):579-84. doi: 10.1007/s00345-006-0103-1. Epub 2006 Aug 9. World J Urol. 2006. PMID: 16896596 Review.

8

Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.

Merseburger AS, Hennenlotter J, Simon P, Müller CC, Kühs U, Knüchel-Clarke R, Moul JW, Stenzl A, Kuczyk MA. Merseburger AS, et al. Oncol Rep. 2006 Jul;16(1):79-83. Oncol Rep. 2006. PMID: 16786126

9

Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.

Merseburger AS, Kramer MW, Hennenlotter J, Simon P, Knapp J, Hartmann JT, Stenzl A, Serth J, Kuczyk MA. Merseburger AS, et al. Prostate. 2008 Jan 1;68(1):72-7. doi: 10.1002/pros.20688. Prostate. 2008. PMID: 18008332

10

Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissue.

Waalkes S, Simon P, Hennenlotter J, Knapp J, Tezval H, Serth J, Stenzl A, Kuczyk MA, Merseburger AS. Waalkes S, et al. Among authors: merseburger as. Oncol Rep. 2010 May;23(5):1257-60. doi: 10.3892/or_00000758. Oncol Rep. 2010. PMID: 20372838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page